Alpha-1 Antitrypsin Deficiency Epidemiology Insights and Forecasts, 2019-2022 & 2023-2032: Focus on United States, EU4 (Germany, France, Italy, Spain) and the United Kingdom, and Japan
April 30, 2024 04:22 ET
|
Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Deficiency - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This 'Alpha-1 Antitrypsin...
Alpha-1 Antitrypsin Deficiency (AATD) Epidemiology Forecast to 2032 Across the 7MM
January 29, 2024 12:07 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Deficiency - Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. This research offers a...
Alpha-1 Antitrypsin Deficiency Market Research Report 2022: Unmet Needs and Opportunities, Treatment Options, Pipeline Assessment, R&D Strategies, Outlook
June 10, 2022 07:48 ET
|
Research and Markets
Dublin, June 10, 2022 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical...
Global Alpha 1 Antitrypsin Deficiency Treatment Markets, 2014-2019 & 2020-2025 by Treatment Type, RoA, End-user, Value Chain, Price Analysis & Competitive Landscape
December 11, 2020 04:28 ET
|
Research and Markets
Dublin, Dec. 11, 2020 (GLOBE NEWSWIRE) -- The "Alpha 1 Antitrypsin Deficiency Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added...
World Outlook for the Alpha Antitrypsin Deficiency (AATD) Market to 2030
September 14, 2020 04:03 ET
|
Research and Markets
Dublin, Sept. 14, 2020 (GLOBE NEWSWIRE) -- The "Alpha Antitrypsin Deficiency (AATD)- Market Insights, Epidemiology and Market Forecast-2030" drug pipelines has been added to ResearchAndMarkets.com's...